Account
Inquiry
QSC tirzepatide is a high-purity pharmaceutical compound available in lyophilized powder form. This GLP-1/GIP receptor agonist is widely used in diabetes and obesity research applications.
The qsc tirzepatide we supply meets strict quality standards with ≥99% purity verified by HPLC analysis. The lyophilized form ensures excellent stability for long-term storage at 2-8°C.
Our qsc tirzepatide is produced under GMP conditions and is suitable for various research applications including formulation development and preclinical studies. The product is supplied in sealed vials to maintain purity and stability.
For weight management research, qsc tirzepatide has shown promising results in clinical studies. The recommended dosage regimen typically starts at 2.5mg weekly with gradual titration up to 15mg weekly based on research requirements.
This product is for research use only, not for human consumption. Proper handling procedures should be followed when working with qsc tirzepatide in laboratory settings.
